Connection

Paul Gurbel to Risk Assessment

Back to Details
This is a "connection" page, showing publications Paul Gurbel has written about Risk Assessment.
Paul Gurbel
Connection Strength
0.157
Risk Assessment
  1. Is There a Role for Preoperative Platelet Function Testing in Patients Undergoing Cardiac Surgery During Antiplatelet Therapy? Circulation. 2018 11 06; 138(19):2145-2159.
    View in: PubMed
    Score: 0.034
  2. Peri-Procedural Platelet Reactivity in Percutaneous Coronary Intervention. Thromb Haemost. 2018 Jul; 118(7):1131-1140.
    View in: PubMed
    Score: 0.033
  3. Selection of P2Y12 Inhibitor in Percutaneous Coronary Intervention and/or Acute Coronary Syndrome. Prog Cardiovasc Dis. 2018 Jan - Feb; 60(4-5):460-470.
    View in: PubMed
    Score: 0.032
  4. Thrombogenicity and central pulse pressure to enhance prediction of ischemic event occurrence in patients with established coronary artery disease: The MAGMA-ischemia score. Atherosclerosis. 2018 01; 268:55-62.
    View in: PubMed
    Score: 0.032
  5. Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients. Eur Heart J Cardiovasc Pharmacother. 2020 07 01; 6(4):203-210.
    View in: PubMed
    Score: 0.010
  6. Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population. Circ Cardiovasc Interv. 2018 10; 11(10):e006853.
    View in: PubMed
    Score: 0.008
  7. Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors. Eur Heart J Cardiovasc Pharmacother. 2017 10 01; 3(4):221-234.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.